nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

01.05.2014 | Glaucoma

The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor

verfasst von: Lisa A. Engel, Philipp S. Muether, Sascha Fauser, Arno Hueber

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate cytokine expression in the aqueous humor of patients with primary open-angle glaucoma (POAG) after previous glaucomatous and/or cataract surgery, and to determine the effect of intraocular pressure (IOP)-lowering eye drops on cytokine expression.

Methods

This prospective consecutive case study included 32 eyes diagnosed with POAG (19 with previous surgery and 13 without previous surgery, treated with topical antiglaucoma medication) and 12 eyes without signs of glaucoma. The Luminex 200 multiplex bead immunoassay was used to measure 27 cytokines in aqueous humor.

Results

Eyes suffering from POAG, with previous surgery, had significantly elevated concentrations of IL-6, IL-8, CCL2, CXCL9, and HGF, and a significantly lower concentration of CCL5, compared to POAG eyes without previous surgery, treated only with topical antiglaucoma medication. When compared with cataract controls, eyes with POAG and previous surgery had significantly elevated levels of G-CSF, IL-8, IL-12, CXCL10, and HGF, and significantly decreased concentrations of IL-17, CCL5, and VEGF in aqueous humor. In a comparison between POAG eyes without previous surgery and cataract controls, the cataract control eyes had significantly higher levels of IL-6 and CCL2, as the only significant difference.

Conclusions

POAG is associated with an aqueous inflammatory response in the aqueous humor, which is significantly elevated in eyes with previous surgery. In contrast, preoperative IOP-lowering eye drops did not significantly alter the anterior chamber milieu. The results of the current study indicate that filtration surgery has a higher success rate in eyes that have not experienced previous surgery.

Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT (2005) Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 331(7509):134PubMedCentralPubMedCrossRef

Broadway DC, Grierson I, Hitchings RA (1998) Local effects of previous conjunctival incisional surgery and the subsequent outcome of filtration surgery. Am J Ophthalmol 125(6):805–818PubMedCrossRef

Law SK, Shih K, Tran DH, Coleman AL, Caprioli J (2009) Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. Am J Ophthalmol 148(5):685–695, e681PubMedCrossRef

Takihara Y, Inatani M, Seto T, Iwao K, Iwao M, Inoue T, Kasaoka N, Murakami A, Futa R, Tanihara H (2011) Trabeculectomy with mitomycin for open-angle glaucoma in phakic vs pseudophakic eyes after phacoemulsification. Arch Ophthalmol 129(2):152–157PubMedCrossRef

Joseph JP, Grierson I, Hitchings RA (1989) Chemotactic activity of aqueous humor. A cause of failure of trabeculectomies? Arch Ophthalmol 107(1):69–74PubMedCrossRef

Broadway DC, Grierson I, O'Brien C, Hitchings RA (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112(11):1446–1454PubMedCrossRef

Sherwood MB, Grierson I, Millar L, Hitchings RA (1989) Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 96(3):327–335PubMedCrossRef

Nuzzi R, Vercelli A, Finazzo C, Cracco C (1995) Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 233(3):154–162PubMedCrossRef

Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint JM, Bechetoille A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106(3):556–563PubMedCrossRef

10.

Chua J, Vania M, Cheung CM, Ang M, Chee SP, Yang H, Li J, Wong TT (2012) Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis 18:431–438PubMedCentralPubMed

11.

Chen KH, Wu CC, Roy S, Lee SM, Liu JH (1999) Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 40(11):2627–2632PubMed

12.

Kuchtey J, Rezaei KA, Jaru-Ampornpan P, Sternberg P Jr, Kuchtey RW (2010) Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci 51(12):6441–6447PubMedCentralPubMedCrossRef

13.

Balaiya S, Edwards J, Tillis T, Khetpal V, Chalam KV (2011) Tumor necrosis factor-alpha (TNF-alpha) levels in aqueous humor of primary open angle glaucoma. Clin Ophthalmol 5:553–556PubMedCentralPubMedCrossRef

14.

Hu DN, Ritch R, Liebmann J, Liu Y, Cheng B, Hu MS (2002) Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes. J Glaucoma 11(5):406–410PubMedCrossRef

15.

Inoue T, Kawaji T, Inatani M, Kameda T, Yoshimura N, Tanihara H (2012) Simultaneous increases in multiple proinflammatory cytokines in the aqueous humor in pseudophakic glaucomatous eyes. J Cataract Refract Surg 38(8):1389–1397PubMedCrossRef

16.

Shima C, Adachi Y, Minamino K, Okigaki M, Shi M, Imai Y, Yanai S, Takahashi K, Ikehara S (2012) Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina. Ophthalmic Res 48(4):199–207PubMedCrossRef

17.

Tsai RK, Chang CH, Sheu MM, Huang ZL (2010) Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Exp Eye Res 90(5):537–545PubMedCrossRef

18.

Cvenkel B, Kopitar AN, Ihan A (2010) Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome. Mediat Inflamm 2010:939602CrossRef

19.

Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610–621PubMedCrossRef

20.

Keeley EC, Mehrad B, Strieter RM (2008) Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol 28(11):1928–1936PubMedCentralPubMedCrossRef

21.

Takai Y, Tanito M, Ohira A (2012) Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci 53(1):241–247PubMedCrossRef

22.

Luna C, Li G, Liton PB, Qiu J, Epstein DL, Challa P, Gonzalez P (2009) Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol 47(1):198–204PubMedCentralPubMedCrossRef

23.

Shifera AS, Trivedi S, Chau P, Bonnemaison LH, Iguchi R, Alvarado JA (2010) Constitutive secretion of chemokines by cultured human trabecular meshwork cells. Exp Eye Res 91(1):42–47PubMedCrossRef

24.

Thirumangalakudi L, Yin L, Rao HV, Grammas P (2007) IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons. J Alzheimers Dis 11(3):305–311PubMed

25.

Goczalik I, Ulbricht E, Hollborn M, Raap M, Uhlmann S, Weick M, Pannicke T, Wiedemann P, Bringmann A, Reichenbach A, Francke M (2008) Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Invest Ophthalmol Vis Sci 49(10):4578–4589PubMedCrossRef

26.

Broadway DC, Lyons CJ, McGillivray BC (1998) Anterior segment dysgenesis and congenital glaucoma associated with partial trisomy of chromosome 1 (1q32-qter). J AAPOS 2(3):188–190PubMedCrossRef

27.

Hong KH, Ryu J, Han KH (2005) Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105(4):1405–1407PubMedCrossRef

28.

Jo N, Wu GS, Rao NA (2003) Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 44(9):4054–4060PubMedCrossRef

29.

Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL 3rd, Chew EY (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46(11):4295–4301PubMedCrossRef

30.

Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, Benowitz L, Hafezi-Moghadam A, Miller JW (2007) Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A 104(7):2425–2430PubMedCentralPubMedCrossRef

31.

Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95(10):3032–3043PubMed

32.

Birchmeier C, Gherardi E (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8(10):404–410PubMedCrossRef

33.

Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C (2004) Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 101(29):10608–10613PubMedCentralPubMedCrossRef

34.

Hu DN, Ritch R (2001) Hepatocyte growth factor is increased in the aqueous humor of glaucomatous eyes. J Glaucoma 10(3):152–157PubMedCrossRef

35.

Tonges L, Ostendorf T, Lamballe F, Genestine M, Dono R, Koch JC, Bahr M, Maina F, Lingor P (2011) Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo. J Neurochem 117(5):892–903PubMedCrossRef

36.

Crane IJ, Kuppner MC, McKillop Smith S, Knott RM, Forrester JV (1998) Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol 184(1):37–44PubMedCrossRef

37.

Khodarev NN, Yu J, Labay E, Darga T, Brown CK, Mauceri HJ, Yassari R, Gupta N, Weichselbaum RR (2003) Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116(Pt 6):1013–1022PubMedCrossRef

38.

Yamagami S, Miyazaki D, Ono SJ, Dana MR (1999) Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci 40(12):2892–2897PubMed

39.

Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9):888–898PubMedCrossRef

40.

Kuiper JJ, Mutis T, De Jager W, De Groot-Mijnes JD, Rothova A (2011) Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy. Am J Ophthalmol 152(2):177–182, e171PubMedCrossRef

41.

Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13(6):711–718PubMedCrossRef

42.

Colin J (2007) The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs 67(9):1291–1308PubMedCrossRef

43.

Fechtner RD, Khouri AS, Zimmerman TJ, Bullock J, Feldman R, Kulkarni P, Michael AJ, Realini T, Warwar R (1998) Anterior uveitis associated with latanoprost. Am J Ophthalmol 126(1):37–41PubMedCrossRef

44.

Byles DB, Frith P, Salmon JF (2000) Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol 130(3):287–291PubMedCrossRef

45.

Kapin MA, Yanni JM, Brady MT, McDonough TJ, Flanagan JG, Rawji MH, Dahlin DC, Sanders ME, Gamache DA (2003) Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. Inflammation 27(5):281–291PubMedCrossRef

46.

Flach AJ (1992) Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 36(4):259–284PubMedCrossRef

47.

Flach AJ (1993) Nonsteroidal anti-inflammatory drugs in ophthalmology. Int Ophthalmol Clin 33(4):1–7PubMedCrossRef

48.

Roberts CW, Brennan KM (1995) A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol 113(6):725–727PubMedCrossRef

49.

Costagliola C, Dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F (2009) Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics. Expert Opin Pharmacother 10(16):2663–2677PubMedCrossRef

50.

Burke J, Schwartz M (1996) Preclinical evaluation of brimonidine. Surv Ophthalmol 41(Suppl 1):S9–S18PubMedCrossRef

51.

Saylor M, McLoon LK, Harrison AR, Lee MS (2009) Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 127(4):402–406PubMedCrossRef

52.

Stamper RL, Wigginton SA, Higginbotham EJ (2002) Primary drug treatment for glaucoma: beta-blockers versus other medications. Surv Ophthalmol 47(1):63–73PubMedCrossRef

53.

Akingbehin T, Villada JR (1991) Metipranolol-associated granulomatous anterior uveitis. Br J Ophthalmol 75(9):519–523PubMedCentralPubMedCrossRef

54.

Moorthy RS, Valluri S, Jampol LM (1998) Drug-induced uveitis. Surv Ophthalmol 42(6):557–570PubMedCrossRef

Titel: The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor
verfasst von: Lisa A. Engel
Philipp S. Muether
Sascha Fauser
Arno Hueber
Publikationsdatum: 01.05.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2014
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-014-2607-5

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Resveratrol and the eye: activity and molecular mechanisms

A novel strategy for the estimation of the general height of the visual field in patients with glaucoma

Structural & functional rehabilitation in eyes with lamina resorption following MOOKP—can the lamina be salvaged?

Adhesiotomy with grafting of fat and perifascial areolar tissue for adhesions of extraocular muscles after trauma or surgery

Choroidal thickness is affected by many factors which may change the effect of ranibizumab

Orthogonal polarization spectral imaging of conjunctival microcirculation

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde